Bristol-Myers CEO Says the Company Is in Transition

preview_player
Показать описание
Bristol-Myers CEO Christopher Boerner says the company is in transition, but he's excited about the strength of recent deals and drugs in their pipeline. He speaks on "Bloomberg Markets" from San Francisco.

Connect with us on...
  1. Bloomberg Television
  2. Bloomberg
Рекомендации по теме
Bristol-Myers CEO Says 0:09:05

Bristol-Myers CEO Says the Company Is in Transition

We have an 0:05:09

We have an accelerated opportunity to renew our portfolio, says Bristol Myers Squibb CEO

Bristol-Myers CEO on 0:05:04

Bristol-Myers CEO on Delta Variant, Return of Office Workforce

Bristol Myers Plans 0:06:54

Bristol Myers Plans to Launch Nine New Drugs, CEO Says

Bristol-Myers Squibb CEO 0:07:03

Bristol-Myers Squibb CEO on the drug pipeline, 2020 outlook and more

Bristol-Myers Squibb CEO 0:02:34

Bristol-Myers Squibb CEO on $13 billion MyoKardia acquisition: 'potentially revolutionary medic...

Bristol-Meyers Squibb CEO 0:07:35

Bristol-Meyers Squibb CEO on Covid-19, Political Contributions

Bristol Myers Squibb 0:01:36

Bristol Myers Squibb CEO expects Zeposia to renew company's medicine portfolio

BMS CEO: We 0:07:54

BMS CEO: We can move at 'incredible speed' on virus

Feedback on schizophrenia 0:02:07

Feedback on schizophrenia treatment has been great, says Bristol Myers Squibb CEO

Bristol-Myers Squibb CEO: 0:09:30

Bristol-Myers Squibb CEO: Drug Pricing Reform | Mad Money | CNBC

Bristol Myers Squibb 0:00:41

Bristol Myers Squibb CEO on $11B cancer drug deal with BioNTech

Bristol Myers CEO 0:03:22

Bristol Myers CEO on Biontech deal: Next new frontier in treatment of cancer

Bristol Myers Squibb 0:03:06

Bristol Myers Squibb CEO on the latest advances in cancer treatment

Bristol Myers CEO 0:05:52

Bristol Myers CEO on Covid Drug Trials, Acquisitions, Texas Plant

Bristol-Myers Squibb CEO 0:09:26

Bristol-Myers Squibb CEO Talks Future of Company | Bloomberg Talks

Bristol Meyers Squibb 0:01:08

Bristol Meyers Squibb CEO on company's drug supply line

Cramer's Mad Dash: 0:02:13

Cramer's Mad Dash: Bristol Myers

We got a 0:07:42

We got a number of important drugs from the Celgene acquisition, says Bristol Myers Squibb CEO

Bristol-Myers' Celgene acquisition 0:06:07

Bristol-Myers' Celgene acquisition is the start of pharmaceutical industry mergers: analyst

Bristol Myers Squibb 0:04:07

Bristol Myers Squibb CEO: We are on track to continue delivering growth

Starboard CEO: 'We 0:01:38

Starboard CEO: 'We are certainly interested in the story at Bristol-Myers'

Bernie Sanders Grills 0:00:52

Bernie Sanders Grills Bristol-Meyers Squibb Executive On High Price Of Drug

2016 WMIF | 0:31:04

2016 WMIF | Fireside Chat: Giovanni Caforio, MD, CEO, Bristol-Myers Squibb

Комментарии
Автор

What are you doing to reduce risk for lawsuits?

MrCLAASS
Автор

Healthcare is the future in the present currently

MichaelMcCausland-pgqs
Автор

i’m not sure this dude could pass an undergrad bio exam

rickjames
Автор

This company is in serious problems. They are having problems launching new products and have a massively bloated middle management

TheBoneruner
Автор

When a CEO does an interview like this, pay careful attention to his eyebrows; Eyebrows answering questions or waiting to answer questions tells alot about stress; This guy looks stressed

SHORT-FRIDAYS
Автор

These tv reporters are soooo clueless, they seam to be adicted to the latest news from morgan stanley and mergers...

markusgarcia
visit shbcf.ru